Trial intelligence / Profile preview

Double trigger versus hCG trigger for final oocyte maturation in normal responders

IRCT20190409043207N3Phase 2Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Sep 2019
Modality
Recombinant Proteins and Enzymes, Small Molecules, Peptides
Countries
1
01

Overview

Phase 2, open-label trial of triptorelin, human chorionic gonadotropin and follitropin alfa in infertility (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Clinical pregnancy rate, Number of follicles and 5 more. Started Sep 2019; status: completed.

02

Drugs

triptorelinhuman chorionic gonadotropinfollitropin alfa
03

Conditions

infertility

Beyond the preview

Go deeper on IRCT20190409043207N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190409043207N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call